Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-8,775
Closed -$530K 1843
2025
Q1
$530K Sell
8,775
-6,725
-43% -$433K 0.01% 1056
2024
Q4
$1.06M Buy
15,500
+9,368
+153% +$653K 0.02% 740
2024
Q3
$441K Buy
6,132
+918
+18% +$64.8K 0.01% 1154
2024
Q2
$361K Sell
5,214
-5,281
-50% -$385K 0.01% 1290
2024
Q1
$840K Buy
+10,495
New +$935K 0.02% 888
2023
Q4
Sell
-15,599
Closed -$1.57M 1849
2023
Q3
$1.57M Buy
+15,599
New +$1.79M 0.06% 467
2022
Q4
Sell
-3,241
Closed -$259K 1628
2022
Q3
$259K Buy
+3,241
New +$306K 0.01% 1221

Other funds holding CNMD

Jump Financial's CNMD Position: Q2 2025 in Review

Jump Financial sold out of CONMED (CNMD) in Q2 2025, closing a stake of 8,775 shares — an estimated $530K sold.

Jump Financial first reported a position in CNMD in Q3 2022 and held it in 7 quarters. The position peaked at $1.57M in Q3 2023. 276 funds tracked by Wall St. Rank hold CNMD as of Q2 2025.

  • Jump Financial reported no remaining CONMED position as of Q2 2025 after selling out during the quarter.
  • Jump Financial sold 8,775 CONMED shares in Q2 2025, an estimated $530K.
  • Jump Financial first reported a position in CONMED in Q3 2022 and held it in 7 quarters.
  • Jump Financial's CONMED position peaked at $1.57M in Q3 2023.
  • 276 funds tracked by Wall St. Rank held CONMED as of Q2 2025.

Based on Jump Financial's 13F filing for Q2 2025, filed 13 Aug 2025.